Effects of FK506 on Ca 2+ Release Channels (Review)
Perspectives in Medicinal Chemistry · 2008
DOI: 10.4137/pmc.s382 ↗Abstract
Tacrolimus (FK506), which was isolated from the fermentation broth of Streptomyces tsukubaensis No. 9993, has an immunosuppressive effect. In T-lymphocytes, FK506 binds to the intracellular receptor, a 12-kDa FK506-binding protein (FKBP12). The FK506-FKBP12 complex binds to the phosphatase calcineurin (CN) and inhibits the activity of CN. By inhibition of the activity of CN, dephosphorylation of a nuclear factor of activated T-cells (NFAT) is inhibited, and translocation of the NFAT to the nucleus is suppressed. Thereby, the production of T-cell-derived mediators such as interleukin 2 (IL-2) is inhibited, and the proliferation of cytotoxic T-cells is suppressed. In muscle cells, FKBP12 and FKBP12.6 are associated with ryanodine-sensitive Ca 2+ release channels (ryanodine receptors: RyRs) on the skeletal and cardiac muscle sarcoplasmic reticulum (SR), respectively. FK506 modulates the RyR by dissociating FKBP12 or FKBP12.6 from the RyR complex. FKBP12 is also associated with inositol 1,4,5-trisphosphate (IP 3 )-sensitive Ca 2+ release channels (IP 3 receptors: IP 3 Rs) on the endoplasmic reticulum (ER) of non-muscle cells. The IP 3 R-FKBP12 complex binds to CN, which dephosphorylates the protein kinase C (PKC) phosphorylation site on the receptor. When FKBP12 is dissociated from the IP 3 R complex by FK506, CN is also dissociated from the IP 3 R. Thereby, the IP 3 R is phosphorylated by PKC, and the receptor is modulated. Recently, it was found that FK506 itself induces Ca 2+ release through RyRs in some tissues.
EUVIMED